Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SUBUTEX
- Extended-release Pharmacotherapy for Opioid Use Disorder
- A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
- SUBLOCADE Rapid Initiation Study
- Medication Treatment for Opioid Use Disorder in Expectant Mothers
- Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
- Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
- Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
- The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels
- Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
- Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
- Buprenorphine Treatment for Opioid Dependence
- Buprenorphine Used With Treatment Resistant Depression in Older Adults
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
- Extended Release Naltrexone for Opioid-Dependent Youth
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
- Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
- Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
- Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
- Transfer of Subjects From Subutex/Suboxone to RBP-6300
- Fetal and Infant Effects of Maternal Buprenorphine Treatment
- Buprenorphine for Treatment Resistant Depression
- Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
- HIV Risk Reduction in Subutex Injectors in Tbilisi
- Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)
- Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")
- Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers
- Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)
- Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
- Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
- Abuse Liability of Suboxone Versus Subutex
- Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
- Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
- A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)
- A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
- HIV Risk Reduction and Drug Abuse Treatment in Iran
- Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
Clinical trials list
click for details